Frank J. Hsu
Chief Medical Officer, Oncternal Therapeutics, Inc.
Companies
- Apexigen, Inc.Chief Medical Officer Aug 8, 2022 to Aug 25, 20231
- Oncternal Therapeutics, Inc.Chief Medical Officer Aug 28, 2019 to Jul 31, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Apexigen, Inc.0 shares3Aug 23, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 23, 2023Returned to company 16,354 shares of Apexigen, Inc.3
- Jun 15, 2023Shares withheld for tax 4,323 shares at $0.49 of Apexigen, Inc.4
- Dec 15, 2022Shares withheld for tax 4,323 shares at $1.06 of Apexigen, Inc.5
- Oct 7, 2022Granted 25,000 shares of Apexigen, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 23, 2023
- 5SEC EDGARForm 4 filed Dec 19, 2022
- 6SEC EDGARForm 4 filed Oct 11, 2022